DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $635,291 | +9.6% | 2,561 | +6.0% | 0.08% | +7.6% |
| Q2 2023 | $579,723 | -0.3% | 2,416 | +4.7% | 0.08% | -14.1% |
| Q1 2023 | $581,559 | -11.1% | 2,307 | -6.4% | 0.09% | -25.8% |
| Q4 2022 | $654,076 | +5.0% | 2,464 | +2.6% | 0.12% | +7.8% |
| Q3 2022 | $623,000 | +5.1% | 2,402 | +2.6% | 0.12% | +3.6% |
| Q2 2022 | $593,000 | -2.8% | 2,340 | +12.6% | 0.11% | +22.0% |
| Q1 2022 | $610,000 | -29.9% | 2,079 | -21.4% | 0.09% | -24.8% |
| Q4 2021 | $870,000 | +6.5% | 2,645 | -1.5% | 0.12% | +13.1% |
| Q3 2021 | $817,000 | -42.0% | 2,684 | -48.8% | 0.11% | +0.9% |
| Q2 2021 | $1,408,000 | +160.7% | 5,244 | +118.7% | 0.11% | +51.4% |
| Q1 2021 | $540,000 | 0.0% | 2,398 | -1.3% | 0.07% | -17.6% |
| Q4 2020 | $540,000 | +5.7% | 2,430 | +2.3% | 0.08% | -5.6% |
| Q3 2020 | $511,000 | +20.8% | 2,375 | -0.8% | 0.09% | +4.7% |
| Q2 2020 | $423,000 | +27.0% | 2,393 | +0.4% | 0.09% | +2.4% |
| Q1 2020 | $333,000 | +122.0% | 2,383 | +126.5% | 0.08% | +64.7% |
| Q2 2019 | $150,000 | +24.0% | 1,052 | +15.1% | 0.05% | +18.6% |
| Q1 2019 | $121,000 | +47.6% | 914 | +15.4% | 0.04% | +19.4% |
| Q4 2018 | $82,000 | -3.5% | 792 | +1.7% | 0.04% | +28.6% |
| Q3 2018 | $85,000 | +34.9% | 779 | +21.5% | 0.03% | +7.7% |
| Q2 2018 | $63,000 | +1.6% | 641 | +1.4% | 0.03% | +44.4% |
| Q1 2018 | $62,000 | +8.8% | 632 | +2.8% | 0.02% | 0.0% |
| Q4 2017 | $57,000 | +11.8% | 615 | +4.1% | 0.02% | -14.3% |
| Q3 2017 | $51,000 | -10.5% | 591 | -16.1% | 0.02% | -12.5% |
| Q2 2017 | $57,000 | -45.7% | 704 | -43.5% | 0.02% | -47.8% |
| Q1 2017 | $105,000 | +110.0% | 1,246 | +92.3% | 0.05% | +119.0% |
| Q4 2016 | $50,000 | +16.3% | 648 | +18.2% | 0.02% | -16.0% |
| Q3 2016 | $43,000 | +16.2% | 548 | +19.4% | 0.02% | +8.7% |
| Q2 2016 | $37,000 | +8.8% | 459 | +29.7% | 0.02% | -17.9% |
| Q1 2016 | $34,000 | +126.7% | 354 | +121.2% | 0.03% | +86.7% |
| Q4 2015 | $15,000 | – | 160 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |